58P Validation of the Achilles VELOS process 2 manufacturing platform for the treatment of solid cancer: GMP scale runs generate a significant dose boost of highly potent clonal neoantigen reactive T-cells
| Autor: | Samuel, E.R., Rologi, E., Fraser, H., Sassi, M., Pruchniak, M., Kotsiou, E., Robinson, J., Benzekhroufa, K., Goodsell, L., Carolan, C., Saggese, M., Grant, M., Samways, B., Kotecha, P., Schmitt, A., Lawrence, D., Forster, M., Turajlic, S., Lowdell, M., Quezada, S. |
|---|---|
| Zdroj: | In Annals of Oncology December 2021 32 Supplement 7:S1396-S1397 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|